SAKK57/16 Nab-paclitaxel and Gemcitabine in Soft Tissue Sarcoma (NAPAGE): a phase I/II trial
Digklia, A, Kollár, A, Dietrich, D, Kronig, M N, Britschgi, C, Rordorf, T, Joerger, M, Krasniqi, F, Metaxas, Y, Colombo, I, Ribi, K, Rothermundt, C
Published in European journal of cancer (1990) (01.01.2024)
Published in European journal of cancer (1990) (01.01.2024)
Get full text
Journal Article
Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)
Metaxas, Y., Früh, M., Eboulet, E.I., Grosso, F., Pless, M., Zucali, P.A., Ceresoli, G.L., Mark, M., Schneider, M., Maconi, A., Perrino, M., Biaggi-Rudolf, C., Froesch, P., Schmid, S., Waibel, C., Appenzeller, C., Rauch, D., von Moos, R.
Published in Annals of oncology (01.04.2020)
Published in Annals of oncology (01.04.2020)
Get full text
Journal Article
SAKK 17/16 - Lurbinectedin monotherapy in patients with progressive malignant pleural mesothelioma: A multicenter, single-arm phase II trial
Metaxas, Y., Xyrafas, A., Mark, M.T., Pless, M., Frueh, M., Froesch, P.R., Schneider, M., Biaggi Rudolf, C., Grosso, F., von Moos, R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase I study of lurbinectedin (PM01183) in combination with cisplatin (CDDP) with or without aprepitant in patients (pts) with advanced solid tumors
Forster, M, Sessa, C, Von Moos, R, Brown, N, Metaxas, Y, Griguolo, G, Lardelli, P, Iglesias, J, Fernandez-Teruel, C, Jandali, U, Soto-Matos, S.M, Stathis, A
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines
Zarkavelis, G., Amylidi, A.L., Verbaanderd, C., Cherny, N.I., Metaxas, Y., de Vries, E.G.E., Zygoura, P., Amaral, T., Jordan, K., Strijbos, M., Dafni, U., Latino, N., Galotti, M., Lordick, F., Giuliani, R., Pignatti, F., Pentheroudakis, G.
Published in ESMO open (01.02.2023)
Published in ESMO open (01.02.2023)
Get full text
Journal Article
Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study
Mark, M., Rusakiewicz, S., Früh, M., Hayoz, S., Grosso, F., Pless, M., Zucali, P., Ceresoli, G.L., Maconi, A., Schneider, M., Froesch, P., Tarussio, D., Benedetti, F., Dagher, J., Kandalaft, L., von Moos, R., Tissot-Renaud, S., Schmid, S., Metaxas, Y.
Published in ESMO open (01.06.2022)
Published in ESMO open (01.06.2022)
Get full text
Journal Article
CT60 single-nucleotide polymorphism as a surrogate marker for donor lymphocyte infusion outcome after allogeneic cell transplantation for acute leukemia
Metaxas, Y, Bertz, H, Spyridonidis, A, Spyroupoulou-Vlachou, M, Porzelius, C, Finke, J
Published in Bone marrow transplantation (Basingstoke) (01.03.2012)
Published in Bone marrow transplantation (Basingstoke) (01.03.2012)
Get full text
Journal Article
316 Phase I study of lurbinectedin (PM01183) in combination with cisplatin (C) with or without aprepitant (Ap) in patients (pts) with advanced solid tumors
Forster, M, Sessa, C, Von Moos, R, Brown, N, Metaxas, Y, Griguolo, G, Lardelli, P, Coronado, C, Juan, L, Fernandez-Teruel, C, Soto-Matos, A, Stathis, A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Human hematopoietic cell transplantation results in generation of donor-derived epithelial cells
Metaxas, Y, Zeiser, R, Schmitt-Graeff, A, Waterhouse, M, Faber, P, Follo, M, Bertz, H, Finke, J, Spyridonidis, A
Published in Leukemia (01.07.2005)
Published in Leukemia (01.07.2005)
Get full text
Journal Article
1495P SAKK 57/16 nab-paclitaxel and gemcitabine in soft tissue sarcoma (NAPAGE): Final results from the phase Ib/II trial with >2y median follow up
Digklia, A., Kollar, A., Kronig, M-N., Britschgi, C., Rordorf, T., Joerger, M., Krasniqi, F., Metaxas, Y., Colombo, I., Dietrich, D., Chiquet, S., Ribi, K., Rothermundt, C.A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
2191P Real-world outcomes of patients with malignant pleural mesothelioma (MPM) treated with combination nivolumab and ipilimumab in the first- or later line setting
Schmid, S., Holer, L., Frueh, M., Koster, K-L., Rothschild, S.I., Britschgi, C., Boos, L., Frehner, L., Almeida, S. Cardoso, Metaxas, Y., Mark, M.T., Froesch, P.R., Janthur, W-D., Allemann, A.T., Waibel, C., Mühll-Schill, C. Vonder, Cerciello, F.W.F., Mauti, L.A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1100P Open-label non-randomized phase IB study to characterize the safety, tolerability and recommended dose of tinostamustin in combination with nivolumab in patients with advanced melanoma (ENIGMA)
Joerger, M., Diem, S., Wyss, N., Koster, K-L., Hess, D., Metaxas, Y., Flynn, M-C., Aeppli, S., El Saadany, T.P., Mane, S., Hiendlmeyer, E., von Moos, R.A.F., Flatz, L.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
557P Binimetinib, pemetrexed (Pem) and cisplatin (Cis), followed by maintenance of Binimetinib and Pem in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations: The phase Ib SAKK 19/16 trial
Froesch, P.R., Mark, M.T., Rothschild, S.I., Li, Q., Godar, G., Rusterholz, C., Schmid, S., Colombo, I., Metaxas, Y., Thut, H.E., Sessa, C., Gautschi, O., Früh, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1570P Outcome and prognostic factors of COVID-19 infection in cancer patients: Final results of SAKK 80/20
Joerger, M., Metaxas, Y., Zaman, K., Michielin, O.A., Mach, N., Betticher, D., Schmitt, A.M., Cantoni, N., Caspar, C.B., Stettler, S., Malval, R., Pless, M., Britschgi, C., Renner, C., Koeberle, D., Schulz, J., Kopp, C., Hayoz, S., Stathis, A., von Moos, R.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
SAKK 57/16 nab-paclitaxel and gemcitabine in soft tissue sarcoma (NAPAGE): Results from the phase I part of a phase I/II trial
Digklia, A., Britschgi, C., Metaxas, Y., Kollar, A., Krasniqi, F., Stathis, A., Rordorf, T., Colombo, I., Mach, N., Hofer, S., Montemurro, M., Stojcheva, N., Dietrich, D., Rothermundt, C.A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1688P - SAKK 57/16 nab-paclitaxel and gemcitabine in soft tissue sarcoma (NAPAGE): Results from the phase I part of a phase I/II trial
Digklia, A., Britschgi, C., Metaxas, Y., Kollar, A., Krasniqi, F., Stathis, A., Rordorf, T., Colombo, I., Mach, N., Hofer, S., Montemurro, M., Stojcheva, N., Dietrich, D., Rothermundt, C.A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
LBA80 Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA)
Joerger, M., Metaxas, Y., Schmitt, A., Koeberle, D., Zaman, K., Betticher, D., Mach, N., Renner, C., Mark, M.T., Petrausch, U., Caspar, C.B., Britschgi, C., Taverna, C., Zenger, F., Mingrone, W., Schulz, J., Kopp, C., Hayoz, S., Stathis, A., von Moos, R.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
575P TLD-1, a novel liposomal doxorubicin, in patients (pts) with advanced solid tumours: Dose escalation part of a multicenter open-label phase I trial (SAKK 65/16)
Hess, D., Colombo, I., Haefliger, S., Bastian, S., Rabaglio, M., Metaxas, Y., Eckhardt, K., Kopp, C., Hayoz, S., Mueller-Schoell, A., Kloft, C., Sessa, C., Stathis, A., Joerger, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article